Burkhard Helmke - Concepedia

Author

Burkhard Helmke

Also Known As

B HELMKE, B Helmke, B M Helmke, B. Helmke, B. M. Helmke, B.M. Helmke, BURKHARD HELMKE, Burkhard Helmke, Burkhard M Helmke, Burkhard M. Helmke

106

Publications

3.9K

Citations

H-Index

121

Concepts

All Affiliations

Heidelberg University German Cancer Research Center University of Bremen University Hospital Heidelberg DKFZ-ZMBH Alliance

About

Burkhard Helmke is an author at Heidelberg University specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	38	1.8K
2	Public Health	5	5	161
3	Health Sciences	3	3	189
4	Natural Sciences	2	2	106
5	Engineering	1	1	23

Burkhard Helmke

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients Felix Zeppernick, Rezvan Ahmadi, Benito Campos, Clinical Cancer Research	2008	588
Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells Benito Campos, Feng Wan, Mohammad Farhadi, Clinical Cancer Research	2010	304
<i>MED12</i> mutations in uterine fibroids—their relationship to cytogenetic subgroups Dominique Nadine Markowski, Sabine Bartnitzke, Thomas Löning, International Journal of Cancer Recurrent Chromosomal AlterationsFibrosisUterine FibroidsSomatic VariantMed12 Mutations	2012	213
HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. P. Rogalla, Klaus Drechsler, Gabriele Frey, PubMed	1996	212
Regulation of <i>DMBT1</i> via NOD2 and TLR4 in Intestinal Epithelial Cells Modulates Bacterial Recognition and Invasion Philip Rosenstiel, Christian Sina, Caroline End, The Journal of Immunology	2007	162
In Situ Expression of Interleukin-10 in Noninflamed Human Gut and in Inflammatory Bowel Disease Frank Autschbach, Jutta Braunstein, Burkhard Helmke, American Journal Of Pathology InflammationNoninflamed Human GutSitu ExpressionMucosal ImmunologyImmunology	1998	151
Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck Simon Ninck, Christoph Reisser, Gerhard Dyckhoff, International Journal of Cancer Hnscc CellsExperimental Cancer TherapiesImmunologyPathologyCell Proliferation	2003	127
DMBT1 Confers Mucosal Protection In Vivo and a Deletion Variant Is Associated With Crohn’s Disease Marcus Renner, Gaby Bergmann, I Krebs, Gastroenterology InflammationChronic Inflammatory DiseasesMucosal ImmunologyCrohn ’Immunology	2007	112
High prevalence of amyloid in 150 surgically removed heart valves—a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions Arnt V. Kristen, Philipp A. Schnabel, Bettina Winter, Cardiovascular Pathology CardiomyopathyHeart FailureStructural Heart DiseaseCardiovascular DiseaseHigh Prevalence	2009	104
Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Jan Mollenhauer, Stephan Herbertz, Burkhard Helmke, PubMed GastroenterologyPathologyExpression PatternCancer BiologyTumor Biology	2001	90

Page 1